These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8691938)

  • 1. US states must cover protease inhibitors.
    Barnett AA
    Lancet; 1996 Jul; 348(9019):52. PubMed ID: 8691938
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinton seeks $65 million for States' AIDS drug programs.
    AIDS Policy Law; 1996 Aug; 11(14):3. PubMed ID: 11363679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A train wreck on board the Titanic.
    Senak M
    J Int Assoc Physicians AIDS Care; 1996 Jul; 2(7):40-1. PubMed ID: 11363745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The marketplace of HIV/AID$.
    Cohen J
    Science; 1996 Jun; 272(5270):1880-1. PubMed ID: 8658155
    [No Abstract]   [Full Text] [Related]  

  • 5. French patients will get protease inhibitors.
    Gozlan M
    Lancet; 1996 Mar; 347(9004):821. PubMed ID: 8622345
    [No Abstract]   [Full Text] [Related]  

  • 6. New York ADAP to cover new AIDS drugs plus viral load testing.
    Link D
    GMHC Treat Issues; 1996 Sep; 10(9):12. PubMed ID: 11363840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAP faces financial abyss. AIDS Drug Assistance Programs.
    Link D
    GMHC Treat Issues; 1996 Feb; 10(2):11-6. PubMed ID: 11363381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New therapeutic possibilities in AIDS].
    Heinzl S
    Med Monatsschr Pharm; 1996 May; 19(5):121. PubMed ID: 8684307
    [No Abstract]   [Full Text] [Related]  

  • 9. ADAP funding seen as insufficient; increases sought.
    AIDS Policy Law; 1997 May; 12(8):6. PubMed ID: 11364308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undetectable viral load in AIDS patients.
    J Assoc Nurses AIDS Care; 1998; 9(1):84-5. PubMed ID: 9436172
    [No Abstract]   [Full Text] [Related]  

  • 11. AIDS. The exorcists.
    Gorman C
    Time; 1996; 148(14):64-6. PubMed ID: 10161476
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment options for human immunodeficiency virus.
    Heins JR
    S D J Med; 1996 Feb; 49(2):51-2. PubMed ID: 9122670
    [No Abstract]   [Full Text] [Related]  

  • 13. Man of the Year. Hope with an asterisk.
    Lacayo R
    Time; 1996 Dec 30-1997 Jan 6; 148(29):82-5. PubMed ID: 10163846
    [No Abstract]   [Full Text] [Related]  

  • 14. International expenditure projections for pharmacotherapeutic advances in the treatment of HIV/AIDS.
    Sclar DA; Robison LM; Skaer TL; Terriff CM; Garrison MW
    Clin Ther; 1997; 19(1):86-95; discussion 84-5. PubMed ID: 9083711
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of protease inhibitors among persons with AIDS in Los Angeles County.
    Sorvillo F; Kerndt PR; Odem S; Castillon M; Carruth A; Contreras R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):179-81. PubMed ID: 9241123
    [No Abstract]   [Full Text] [Related]  

  • 16. Glaxo, Merck and ADAP.
    GMHC Treat Issues; 1996 May; 10(5):8. PubMed ID: 11363584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: time to end the death trials.
    James JS
    AIDS Treat News; 1996 Aug; (no 252):1-4. PubMed ID: 11363751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The end of AIDS?
    Leland J
    Newsweek; 1996 Dec; 128(23):64-8, 71, 73. PubMed ID: 10162943
    [No Abstract]   [Full Text] [Related]  

  • 19. The molecular basis of anti-retroviral therapy.
    Weber J
    J Antimicrob Chemother; 1993 Dec; 32(6):789-92. PubMed ID: 7511578
    [No Abstract]   [Full Text] [Related]  

  • 20. New anti-HIV drugs and treatment strategies buoy AIDS researchers.
    Stephenson J
    JAMA; 1996 Feb; 275(8):579-80. PubMed ID: 8594227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.